98 related articles for article (PubMed ID: 2592796)
1. Acute lipidemic effect of calcium heparin in normolipemic and hyperlipemic subjects.
Ferlito S; Ricceri M; Ossino AM
Int Angiol; 1989; 8(3):140-4. PubMed ID: 2592796
[TBL] [Abstract][Full Text] [Related]
2. Lipidemic effects of a mild-term treatment with calcium heparin in vasculopathic subjects.
Ferlito S; Ossino AM; Puleo M; Puleo R; Di Mauro C
Panminerva Med; 1989; 31(4):171-6. PubMed ID: 2633106
[TBL] [Abstract][Full Text] [Related]
3. Reversible increase of the apo CII/apo CIII-1 ratio in the very low density lipoproteins after procetofen treatment in hypertriglyceridemic patients.
Franceschini G; Sirtori M; Gianfranceschi G; Frosi T; Montanari G; Sirtori CR
Artery; 1985; 12(6):363-81. PubMed ID: 4051756
[TBL] [Abstract][Full Text] [Related]
4. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
[TBL] [Abstract][Full Text] [Related]
5. [Effect of omega-3-fatty acids on lipoprotein metabolism. Different effects in various phenotypes].
Singer P; Hüve J
Fortschr Med; 1991 Aug; 109(24):476-9. PubMed ID: 1937329
[TBL] [Abstract][Full Text] [Related]
6. [Cholesterol fractions in subjects with cerebral, coronary and peripheral vasculopathy].
Ferlito S; Ricceri M; Di Mauro C
Minerva Cardioangiol; 1989; 37(1-2):61-6. PubMed ID: 2725910
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of apoproteins A and B, lipoproteins and plasma lipids during treatment with bezafibrate in various forms of hyperlipoproteinemia].
Saitta A; Bonaiuto M; Lanzafame F; Mileto A; Pernice F; Cinquegrani M; Mazza G; Micali G; Pangallo A; Fodale P
Clin Ter; 1988 Mar; 124(5):373-81. PubMed ID: 2974348
[No Abstract] [Full Text] [Related]
8. [Rapid effect of glucuronyl glucosamine glycan sulfate on the blood levels of HDL-cholesterol in vascular diseases].
Ferlito S; La Spina E; Cultrera E; Puleo F; Carrà G
Arch Sci Med (Torino); 1982; 139(2):175-81. PubMed ID: 7138283
[TBL] [Abstract][Full Text] [Related]
9. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
10. Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
Antikainen M; Holmberg C; Taskinen MR
Clin Nephrol; 1994 May; 41(5):284-9. PubMed ID: 8050208
[TBL] [Abstract][Full Text] [Related]
11. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
[TBL] [Abstract][Full Text] [Related]
12. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
Reyna-Villasmil N; Bermúdez-Pirela V; Mengual-Moreno E; Arias N; Cano-Ponce C; Leal-Gonzalez E; Souki A; Inglett GE; Israili ZH; Hernández-Hernández R; Valasco M; Arraiz N
Am J Ther; 2007; 14(2):203-12. PubMed ID: 17414591
[TBL] [Abstract][Full Text] [Related]
13. [Lipids, lipoproteins and apolipoproteins in normal newborns].
Casanueva V; Cid X; Chiang MT; Molina M; Ferrada MC; Pérez R; Casanueva P
Rev Med Chil; 1998 Sep; 126(9):1073-8. PubMed ID: 9922510
[TBL] [Abstract][Full Text] [Related]
14. Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: prevalence and precipitating factors.
Lowry RP; Soltys G; Mangel R; Kwiterovitch P; Sniderman AD
Transplant Proc; 1987 Feb; 19(1 Pt 3):2229-32. PubMed ID: 3547921
[No Abstract] [Full Text] [Related]
15. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
Superko HR; Berneis KK; Williams PT; Rizzo M; Wood PD
Am J Cardiol; 2005 Nov; 96(9):1266-72. PubMed ID: 16253595
[TBL] [Abstract][Full Text] [Related]
16. [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia].
Pristautz H; Stradner F
Wien Med Wochenschr; 1986 Sep; 136(17):443-8. PubMed ID: 2879389
[TBL] [Abstract][Full Text] [Related]
17. [Blood lipid and apolipoprotein concentrations in a healthy urban population of Northern Cameroon: variation with age and sex].
Ndomou M; Ngogang J; Kenne M
Sante; 1999; 9(3):169-72. PubMed ID: 10477406
[TBL] [Abstract][Full Text] [Related]
18. Lipid and apolipoproteins (ApoAI, ApoB, Apo CIII, ApoE) disturbance in hemodialysis (HD) and renal transplant (Tx) patients.
Janicki K; Solski J; Janicka L; Kimak E; Bednarek-Skublewska A; Stettner S; Molas G
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):459-66. PubMed ID: 16146031
[TBL] [Abstract][Full Text] [Related]
19. [HDL, HDL2 and HDL3 cholesterol in various types of hyperlipoproteinemia in relation to clinical signs of arteriosclerosis].
Sznajderman M; Zawadzki Z
Kardiol Pol; 1986; 29(3):194-203. PubMed ID: 3773408
[No Abstract] [Full Text] [Related]
20. [High-density lipoprotein cholesterol and the atherogenic index in patients with different types of hyperlipoproteinemias].
Apostolov I; Naumova R; Balabanski L; Goranov I
Vutr Boles; 1983; 22(3):70-4. PubMed ID: 6649586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
